RxDoctor Payments Data

Samantha Kiefer, DO

Family Medicine · Conneaut, OHNPI 1295114387

Payments from drug & device makers

$378in general payments, 2019–2025

Across 20 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$98
  • Pfizer$70
  • AstraZeneca$67
  • Novo Nordisk$36
  • Verona Pharma, Inc.$28
  • Almatica Pharma LLC$24
  • plus $55 from 3 others

What the payments were for

  • Food & beverage$35494%
  • Education$246%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$378 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$87,652
Medicare patients
341
Services billed
1,318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$126,178
TrulicityDulaglutide94$114,821
OzempicSemaglutide90$95,422
JardianceEmpagliflozin95$91,287
CreonLipase/Protease/Amylase22$43,210
XareltoRivaroxaban45$41,145
JanuviaSitagliptin Phosphate28$30,796
FarxigaDapagliflozin Propanediol11$16,479
Nurtec OdtRimegepant Sulfate14$13,760
LinzessLinaclotide14$13,117
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$11,800
Spiriva RespimatTiotropium Bromide23$11,661
Tresiba Flextouch U-100Insulin Degludec20$11,109
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$8,726
SymbicortBudesonide/Formoterol Fumarate23$8,679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$70$139,938145 claims
Lilly USA, LLCTrulicity$17$114,82194 claims
Novo NordiskOzempic$36$95,42290 claims
AbbVieCreon, Linzess, Synthroid$98$58,815100 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$67$36,95847 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Conneaut

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →